hepatitis C virus infection
hepatitis C virus infection
Explore linked clinical trials. Standard reference: MONDO:000523190 results · Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Early phase 1 | 2026-10-09 | NCT06159504 | |
| Blood Collection Biorepository for Liver Disease Research | Blood-Borne Infections, Body Weight, DNA Virus Infections, Digestive System Diseases, Fibrosis, Flaviviridae infectious disease, Hepadnaviridae infectious disease, Infections, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, RNA Virus Infections, Signs and Symptoms, cirrhosis of liver, fatty liver disease, hepatitis, hepatitis B virus infection, hepatitis C virus infection, infectious disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-10-08 | NCT03025074 | |
| People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents | Blood-Borne Infections, Chronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Fibrosis, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, adenocarcinoma, carcinoma, cardiovascular disorder, chronic hepatitis C virus infection, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hepatitis, hepatitis C virus infection, hepatocellular carcinoma, infectious disease, liver disorder, metabolic disease, neoplasm, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 4 | 2026-10-02 | NCT03520660 | |
| Comparative Autoantibody and Immunologic Cell Marker Study | AIDS, Blood-Borne Infections, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Epstein-Barr virus infection, Flaviviridae infectious disease, Genital Diseases, Guillain-Barre syndrome, HIV infectious disease, Hemic and Lymphatic Diseases, Hemorrhage, Herpesviridae infectious disease, Immunoglobulin G4-Related Disease, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, Purpura, Thrombocytopenic, Idiopathic, RNA Virus Infections, Sepsis, Signs and Symptoms, Sjogren syndrome, Skin Manifestations, Skin and Connective Tissue Diseases, Slow Virus Diseases, Stomatognathic Diseases, Systemic Inflammatory Response Syndrome, Tumor Virus Infections, Undifferentiated Connective Tissue Diseases, Urogenital Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, autoimmune lymphoproliferative syndrome, blood coagulation disease, blood platelet disease, connective tissue disorder, demyelinating disease, diffuse scleroderma, dry eye syndrome, eye disorder, graft versus host disease, hematologic disorder, hemorrhagic disease, hepatitis, hepatitis C virus infection, hereditary disease, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, juvenile idiopathic arthritis, lacrimal apparatus disorder, lentivirus infection, liver disorder, lymphatic system disorder, lymphoproliferative syndrome, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy, purpura, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, sexually transmitted disease, skin disorder, systemic lupus erythematosus, systemic sclerosis, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Not stated | 2026-10-01 | NCT02422875 | |
| Evaluation of Patients With Liver Disease | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Flaviviridae infectious disease, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, hepatitis, hepatitis B virus infection, hepatitis C virus infection, hepatitis D virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-10-01 | NCT00001971 | |
| Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not applicable | 2026-09-29 | NCT04162938 | |
| The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-09-28 | NCT05713136 | |
| The National Australian HCV Point-of-Care Testing Program - Minimal Dataset | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-09-28 | NCT05248555 | |
| The Australian HCV Point-of-Care Testing Program | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-09-28 | NCT05042544 | |
| A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07237282 | |
| Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening | Blood-Borne Infections, Digestive System Diseases, Digestive System Neoplasms, Flaviviridae infectious disease, Infections, Neoplasms by Site, RNA Virus Infections, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, hepatitis, hepatitis C virus infection, infectious disease, intestinal disorder, liver disorder, neoplasm, rectal disorder, viral hepatitis, viral infectious disease | Recruiting | Not applicable | 2026-09-16 | NCT06745895 | |
| Buprenorphine Integration Research and Community Health | Blood-Borne Infections, Chemically-Induced Disorders, Digestive System Diseases, Flaviviridae infectious disease, Genital Diseases, HIV infectious disease, Infections, Narcotic-Related Disorders, Opioid Use Disorder, RNA Virus Infections, Urogenital Diseases, hepatitis, hepatitis C virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, opiate dependence, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-09-14 | NCT05668780 | |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Blood-Borne Infections, Chronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, adenocarcinoma, carcinoma, epithelial neoplasm, hepatitis, hepatitis C virus infection, hepatocellular carcinoma, infectious disease, liver disorder, neoplasm, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 1 | 2026-09-11 | NCT02772003 | |
| AI-Powered Hepatitis C Single-Encounter Test-and-Treat | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 4 | 2026-08-28 | NCT07793643 | |
| Strengthening, Guidance, Health, Empowerment | Bacterial Infections and Mycoses, Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Flaviviridae infectious disease, Genital Diseases, HIV infectious disease, Hepadnaviridae infectious disease, Infections, RNA Virus Infections, Treponema infectious disease, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, chlamydia infectious disease, chlamydiaceae infections, gram-negative bacterial infections, hepatitis, hepatitis B virus infection, hepatitis C virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, sexually transmitted disease, spirochaetales infections, syphilis, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not applicable | 2026-08-26 | NCT07788599 | |
| Treatment of CKD Patients With HCV | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 2 / Phase 3 | 2026-08-20 | NCT07770984 | |
| Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk | AIDS, Blood-Borne Infections, Chemically-Induced Disorders, Digestive System Diseases, Disease Attributes, Drug Misuse, Drug Overdose, Flaviviridae infectious disease, Genital Diseases, HIV infectious disease, Infections, Narcotic-Related Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prescription Drug Misuse, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, hepatitis, hepatitis C virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, opiate dependence, psychiatric disorder, sexually transmitted disease, substance abuse, substance-related disorder, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-08-18 | NCT05657106 | |
| Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil) | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 4 | 2026-08-17 | NCT06306300 | |
| Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-08-14 | NCT07040319 | |
| Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic | Bacterial Infections and Mycoses, Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Flaviviridae infectious disease, Genital Diseases, Hepadnaviridae infectious disease, Infections, RNA Virus Infections, Treponema infectious disease, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, gram-negative bacterial infections, hepatitis, hepatitis B virus infection, hepatitis C virus infection, infectious disease, liver disorder, sexually transmitted disease, spirochaetales infections, syphilis, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-08-13 | NCT07317687 | |
| Project I Test: Implementing HIV Testing in Opioid Treatment Programs | AIDS, Blood-Borne Infections, Chemically-Induced Disorders, Digestive System Diseases, Flaviviridae infectious disease, Genital Diseases, HIV infectious disease, Infections, Narcotic-Related Disorders, RNA Virus Infections, Slow Virus Diseases, Substance Use Disorders, Urogenital Diseases, hepatitis, hepatitis C virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, opiate dependence, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-08-07 | NCT03135886 | |
| North Jersey Community Research Initiative (NJCRI) Study on Transgender Liver Health | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Enrolling by invitation | Not stated | 2026-08-05 | NCT07746999 | |
| Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 4 | 2026-07-29 | NCT03855917 | |
| Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Fibrosis, Flaviviridae infectious disease, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, cancer, chronic obstructive pulmonary disease, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hepatitis, hepatitis B virus infection, hepatitis C virus infection, infectious disease, liver disorder, lung disorder, metabolic disease, neoplasm, obstructive lung disease, respiratory system disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-07-10 | NCT05181826 | |
| The HOPE Study: Characterizing Patients With Hepatitis B and C | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Flaviviridae infectious disease, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Not stated | 2026-07-01 | NCT02995252 |